H2S as a Therapeutic Adjuvant Against COVID-19: Why and How?
Shock
.
2021 Nov 1;56(5):865-867.
doi: 10.1097/SHK.0000000000001723.
Authors
Thomas Datzmann
1
,
Tamara Merz
1
,
Oscar McCook
1
,
Csaba Szabo
2
,
Peter Radermacher
1
Affiliations
1
Institute for Anesthesiological Pathophysiology and Process Engineering, University Hospital, Ulm, Germany.
2
Chair of Pharmacology, OMI Department, Section of Science and Medicine, University of Fribourg, Fribourg, Switzerland.
PMID:
33443365
PMCID:
PMC8518209
DOI:
10.1097/SHK.0000000000001723
No abstract available
Publication types
Comment
MeSH terms
COVID-19*
Humans
Hydrogen Sulfide*
SARS-CoV-2
Signal Transduction
Substances
Hydrogen Sulfide